SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  December 2021 of Rs. 938.36 millions grew by 5.81 % from Rs. 886.87 millions.Profit after Tax for the quarter ended December 2021 saw a decline of -37.48% from Rs. 64.33 millions to Rs. 40.22  millions.Operating Profit saw a handsome growth to 143.13 millions from 138.70 millions in the quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 938.36 886.87 5.81 3128.16 2893.54 8.11 3801.41 2823.54 34.63
Other Income 80.42 12.68 534.23 173.85 26.07 566.86 47.21 11.81 299.75
PBIDT 143.13 138.70 3.19 389.46 464.46 -16.15 580.20 248.75 133.25
Interest 26.87 23.48 14.44 86.27 71.10 21.34 93.26 104.05 -10.37
PBDT 116.26 115.22 0.90 303.19 393.36 -22.92 486.94 144.70 236.52
Depreciation 26.72 23.34 14.48 75.63 66.60 13.56 91.75 82.18 11.65
PBT 89.54 91.88 -2.55 227.56 326.76 -30.36 395.19 62.52 532.10
TAX 49.32 27.55 79.02 97.90 68.61 42.69 115.48 -20.01 -677.11
Deferred Tax 11.19 0.00 0.00 22.86 0.00 0.00 22.80 -20.54 -211.00
PAT 40.22 64.33 -37.48 129.66 258.15 -49.77 279.71 82.53 238.92
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 15.25 15.64 -2.47 12.45 16.05 -22.44 15.26 8.81 73.25

Mangalam Drugs&Org. Share Price

29.75 0.02 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×